China News Service, May 19. According to the website of the State Drug Administration, the State Drug Administration recently organized an unannounced inspection of Guangzhou Zhuangyan Biotechnology Co., Ltd.
After investigation, it was found that the company violated relevant regulations such as the Regulations on Supervision and Administration of Cosmetics and the Work Regulations for Cosmetics Production License.
The company has confirmed the existence of the problem.
In order to ensure the safety of public use of makeup, the State Drug Administration has instructed the Guangdong Provincial Drug Administration to file an investigation into the company.
The inspection results announced by the State Food and Drug Administration showed that the company had incomplete production process and operating procedures in terms of production management, suspected of producing inconsistent cosmetics with filing formulas, etc.; there was an unreasonable layout of related functions in the production workshop in terms of plant and facilities. In addition, there are problems such as failure to use the set functions; in terms of equipment management, the cleaning and maintenance of the water system is not in place, and there are problems such as fouling and mold stains in the flowmeter; in terms of quality management, there are problems such as failure to retain samples in accordance with regulations and labels and labels of semi-finished products. Issues such as inconsistency in kind.